Sound Pharmaceuticals enrolls first patient in STOP Ototoxicity phase II study of SPI-1005 Jan. 15, 2019
Phase II data for PF-04457845 as potential treatment of cannabis withdrawal and dependence Jan. 15, 2019
INTS1 gene variants tied to intellectual disability with eye defects and craniofacial anomalies Jan. 15, 2019
Targeting transferrin receptor protein 2 knockout alleviates anemia in a model of beta-thalassemia Jan. 15, 2019
RSS